Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro

Antiviral Res. 2009 Oct;84(1):95-7. doi: 10.1016/j.antiviral.2009.07.010. Epub 2009 Jul 25.

Abstract

The anti-herpes simplex virus (HSV) compound, oxyresveratrol, purified from a Thai traditional medicinal plant of Artocarpus lakoocha, was evaluated for its anti-varicella-zoster virus (VZV) activity. This compound exhibited IC(50) values (50%-inhibitory concentrations for virus plaque formation) of 12.82, 12.80, 12.99 and 12.82 microg/ml against wild type, thymidine kinase-deficient and two types of DNA polymerase mutants with acyclovir-resistance, respectively. Thus oxyresveratrol showed a broad spectrum of anti-VZV activity with a mechanism of action different from that of acyclovir.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology*
  • Cell Line
  • Chickenpox / virology*
  • Drug Resistance, Viral*
  • Herpesvirus 3, Human / drug effects*
  • Herpesvirus 3, Human / genetics
  • Herpesvirus 3, Human / physiology
  • Humans
  • Plant Extracts / pharmacology*
  • Stilbenes / pharmacology*
  • Virus Replication / drug effects*

Substances

  • Antiviral Agents
  • Plant Extracts
  • Stilbenes
  • puag-haad